HelloMD Announces Partnership with Medical Cannabis Provider
PharmaCannis
Collaboration will begin immediately in New York
State with additional states to follow
SAN FRANCISCO - June 22, 2017
(Investorideas.com Newswire) HelloMD, the nation's largest community of medical
cannabis patients, experts, and trusted brands, announced today that they have
partnered with PharmaCannis, a multi-region, vertically integrated medical
cannabis provider. The two companies will work together to provide a complete
end-to-end medical cannabis solution to existing and new patients. This
collaboration will result in expanded access to cannabis expertise, physicians,
education, and medical cannabis products. Effective immediately, HelloMD and
PharmaCannis will focus on providing services in New York, with other states to
follow.
In the past year, New York State
has experienced significant and challenging growing pains since opening its
program to patients. However, the recent addition of chronic pain to the list
of qualifying conditions, coupled with a growing supply of certified healthcare
practitioners who are qualified to make a medical cannabis recommendation, the
program has seen a spike in demand.
Read this news in
full at http://www.investorideas.com/news/2017/marijuana/06221HelloMD.asp
Marijuana /
Hemp Stocks
Like Marijuana
Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group
on Linkedin - Marijuana / Hemp Stocks
- News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis
news
Get News Alerts on
Marijuana Stocks
Watch the 420 Cannabis Investor video
More Info:
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third
party sourced news, articles and equity research as well as creates original
content, including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment